These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9430687)

  • 1. Structures that delineate orphanin FQ and dynorphin A pharmacological selectivities.
    Reinscheid RK; Higelin J; Henningsen RA; Monsma FJ; Civelli O
    J Biol Chem; 1998 Jan; 273(3):1490-5. PubMed ID: 9430687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of [3H]orphanin FQ and 125I-Tyr14-orphanin FQ with the orphanin FQ receptor: kinetics and modulation by cations and guanine nucleotides.
    Ardati A; Henningsen RA; Higelin J; Reinscheid RK; Civelli O; Monsma FJ
    Mol Pharmacol; 1997 May; 51(5):816-24. PubMed ID: 9145920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo).
    Bird MF; Cerlesi MC; Brown M; Malfacini D; Vezzi V; Molinari P; Micheli L; Di Cesare Mannelli L; Ghelardini C; Guerrini R; Calò G; Lambert DG
    PLoS One; 2016; 11(6):e0156897. PubMed ID: 27272042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.
    Meunier JC
    Eur J Pharmacol; 1997 Dec; 340(1):1-15. PubMed ID: 9527501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capsaicin inhibits the in vitro binding of peptides selective for mu- and kappa-opioid, and nociceptin-receptors.
    Wollemann M; Ioja E; Benyhe S
    Brain Res Bull; 2008 Sep; 77(2-3):136-42. PubMed ID: 18588953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional selectivity of orphanin FQ for its receptor coexpressed with potassium channel subunits in Xenopus laevis oocytes.
    Matthes H; Seward EP; Kieffer B; North RA
    Mol Pharmacol; 1996 Sep; 50(3):447-50. PubMed ID: 8794880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic.
    Thompson AA; Liu W; Chun E; Katritch V; Wu H; Vardy E; Huang XP; Trapella C; Guerrini R; Calo G; Roth BL; Cherezov V; Stevens RC
    Nature; 2012 May; 485(7398):395-9. PubMed ID: 22596163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the structure-activity relationships of nociceptin and dynorphin A using chimeric peptides.
    Lapalu S; Moisand C; Mazarguil H; Cambois G; Mollereau C; Meunier JC
    FEBS Lett; 1997 Nov; 417(3):333-6. PubMed ID: 9409745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nociceptin/orphanin FQ (N/OFQ)--the opioid, antiopioid or neuromodulator?].
    Kotlińska J; Rafalski P
    Postepy Hig Med Dosw (Online); 2004 Apr; 58():209-15. PubMed ID: 15114256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete knockout of the nociceptin/orphanin FQ receptor in the rat does not induce compensatory changes in mu, delta and kappa opioid receptors.
    Homberg JR; Mul JD; de Wit E; Cuppen E
    Neuroscience; 2009 Sep; 163(1):308-15. PubMed ID: 19527777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of Nociceptin/Orphanin FQ Peptide Analogs for Drug Development.
    Wtorek K; Janecka A
    Chem Biodivers; 2021 Jan; 18(1):e2000871. PubMed ID: 33351271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of nociceptin/orphanin FQ binding sites in dog brain membranes.
    Johnson EE; Gibson H; Nicol B; Zanzinger J; Widdowson P; Hawthorn M; Toth G; Farkas J; Guerrini R; Lambert DG
    Anesth Analg; 2003 Sep; 97(3):741-747. PubMed ID: 12933394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human peripheral blood mononuclear cells express nociceptin/orphanin FQ, but not mu, delta, or kappa opioid receptors.
    Williams JP; Thompson JP; McDonald J; Barnes TA; Cote T; Rowbotham DJ; Lambert DG
    Anesth Analg; 2007 Oct; 105(4):998-1005, table of contents. PubMed ID: 17898379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test.
    Chen X; Geller EB; Adler MW
    Eur J Pharmacol; 2007 Feb; 557(1):32-6. PubMed ID: 17173891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.
    Molinari S; Camarda V; Rizzi A; Marzola G; Salvadori S; Marzola E; Molinari P; McDonald J; Ko MC; Lambert DG; Calo' G; Guerrini R
    Br J Pharmacol; 2013 Jan; 168(1):151-62. PubMed ID: 22827708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency.
    Lung FD; Meyer JP; Lou BS; Xiang L; Li G; Davis P; DeLeon IA; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Jun; 39(13):2456-60. PubMed ID: 8691442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nociceptin/orphanin FQ decreases serotonin efflux in the rat brain but in contrast to a kappa-opioid has no antagonistic effect on mu-opioid-induced increases in serotonin efflux.
    Tao R; Ma Z; Thakkar MM; McCarley RW; Auerbach SB
    Neuroscience; 2007 Jun; 147(1):106-16. PubMed ID: 17499930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nociceptin (ORL-1) and mu-opioid receptors mediate mitogen-activated protein kinase activation in CHO cells through a Gi-coupled signaling pathway: evidence for distinct mechanisms of agonist-mediated desensitization.
    Hawes BE; Fried S; Yao X; Weig B; Graziano MP
    J Neurochem; 1998 Sep; 71(3):1024-33. PubMed ID: 9721727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity.
    Guerrini R; Carra' G; Calo' G; Trapella C; Marzola E; Rizzi D; Regoli D; Salvadori S
    J Pept Res; 2004 Jun; 63(6):477-84. PubMed ID: 15175020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.